Image

Rasburicase Treatment in Chronic Gouty Arthritis

Recruiting
18 - 70 years of age
Both
Phase 4

Powered by AI

Overview

The study will establish efficacy and safety of rasburicase in chronic gouty arthritis

Description

The study hypothesis is that the proportion of patients who achieved the primary endpoint after 12 weeks of treatment with rasburicase combined with oral urate-lowering therapy is superior to 12 weeks of treatment with oral urate-lowering therapy.

Eligibility

Inclusion Criteria:

  • Written informed consent must be obtained before any assessment is performed, able to understand and comply with the requirements of the study;
  • Male and female patients 18 to 70 years of age;
  • Fulfill the ACR/EULAR 2015 gout classification criteria;
  • Tophi detected by physical examination;
  • Serum urate>300μmol/L (5mg/dl) after one-month maximum dose of urate-lowering therapy (allopurinol 600mg/d or febuxostat 80mg/d in combination with benzbromarone 100mg/d) unless intolerable OR no reduction in size of tophi after serum urate<300μmol/L (5mg/dl) for six month;

Exclusion Criteria:

  • Pregnant women, lactating women, and men or women who have recently prepared for pregnancy;
  • Abnormal liver function with AST, ALT, and GGT >3 times ULN;
  • Blood WBC<4.0×10^9/L, and/or hemoglobin <90g/L, and/or platelets;<100×10^9/L; or other hematologic disorders;
  • eGFR<15 ml/min;
  • Receive following medications: azathioprine, mercaptopurine, cyclosporine, pyrazinamide, ethambutol and sulfamethoxazole
  • Psychiatric disorders, history of alcoholism, drug or other substance abuse
  • Immunodeficiency diseases, uncontrolled infection, etc;
  • Sericosis, glucose-6-phosphate dehydrogenase activity deficiency
  • Allergy to biological agents and chronic active urticaria.

Study details

Chronic Gout

NCT05312268

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.